QM/MM simulations identify the determinants of catalytic activity differences between type II dehydroquinase enzymes by Lence, Emilio et al.
                          Lence Quintana, E., Van der Kamp, M., González-Bello, C., & Mulholland,
A. (2018). QM/MM simulations identify the determinants of catalytic
activity differences between type ii dehydroquinase enzymes. Organic and
Biomolecular Chemistry, 16(24), 4443-4455.
https://doi.org/10.1039/C8OB00066B
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1039/C8OB00066B
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Royal Society of
Chemistry at http://pubs.rsc.org/en/Content/ArticleLanding/2018/OB/C8OB00066B#!divAbstract. Please refer to
any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Organic &
 Biomolecular 
Chemistry
rsc.li/obc
ISSN 1477-0520
 PAPER 
 Marc W. van der Kamp, Concepción González-Bello, 
Adrian J. Mulholland  et al. 
 QM/MM simulations identify the determinants of catalytic activity 
diff erences between type II dehydroquinase enzymes 
Volume 16  Number 24  28 June 2018  Pages 4375–4572
Organic &
Biomolecular Chemistry
PAPER
Cite this: Org. Biomol. Chem., 2018,
16, 4443
Received 9th January 2018,
Accepted 18th April 2018
DOI: 10.1039/c8ob00066b
rsc.li/obc
QM/MM simulations identify the determinants of
catalytic activity diﬀerences between type II
dehydroquinase enzymes†
Emilio Lence, ‡a,b Marc W. van der Kamp, *‡a,c
Concepción González-Bello *b and Adrian J. Mulholland*a
Type II dehydroquinase enzymes (DHQ2), recognized targets for antibiotic drug discovery, show signiﬁ-
cantly diﬀerent activities dependent on the species: DHQ2 from Mycobacterium tuberculosis (MtDHQ2)
and Helicobacter pylori (HpDHQ2) show a 50-fold diﬀerence in catalytic eﬃciency. Revealing the deter-
minants of this activity diﬀerence is important for our understanding of biological catalysis and further
oﬀers the potential to contribute to tailoring speciﬁcity in drug design. Molecular dynamics simulations
using a quantum mechanics/molecular mechanics potential, with correlated ab initio single point correc-
tions, identify and quantify the subtle determinants of the experimentally observed diﬀerence in
eﬃciency. The rate-determining step involves the formation of an enolate intermediate: more eﬃcient
stabilization of the enolate and transition state of the key step in MtDHQ2, mainly by the essential residues
Tyr24 and Arg19, makes it more eﬃcient than HpDHQ2. Further, a water molecule, which is absent in
MtDHQ2 but involved in generation of the catalytic Tyr22 tyrosinate in HpDHQ2, was found to destabilize
both the transition state and the enolate intermediate. The quantiﬁcation of the contribution of key
residues and water molecules in the rate-determining step of the mechanism also leads to improved
understanding of higher potencies and speciﬁcity of known inhibitors, which should aid ongoing inhibitor
design.
Introduction
It is well known that the catalytic eﬃciency of homologous
enzymes can vary significantly depending on the species. In
most cases the active site of homologous enzymes is highly
conserved, and it is generally not obvious how other diﬀer-
ences in amino acid sequence may aﬀect activity.
Understanding such diﬀerences can be used for designing
specific inhibitors against enzymes, for example for developing
new drug candidates to combat pathogenic bacteria that have
developed resistance against existing antibiotics. The emer-
gence and worldwide spread of multidrug-resistant microbial
strains is one of the most important challenges for public
health in the 21st century.1–3 The lack of eﬀective antibiotics is
currently undermining our ability to deal with infectious dis-
eases, and to manage complications in vulnerable patients
undergoing general surgery, organ transplantation, dialysis
and chemotherapy for cancer, for which the ability to treat sec-
ondary infections is crucial. It has been estimated that if anti-
biotic resistance continues rising at this rate we will pass from
the current 700 000 deaths annually to about 10 million (one
every 3 seconds) in 2050.4,5 Most of the antibiotics in clinical
use target the same type of bacterial functions and resistance
to them is now widespread and well known. It is therefore not
surprising that much eﬀort is currently being devoted to
search not only for more eﬀective antibiotics, but also to
develop novel chemical entities disabling unexploited essential
processes in bacteria. In this context, it is relevant to study the
biochemical behavior of those unexplored targets in
detail.1–3,6–8
A particular goal is to develop more specific antimicrobials,
i.e. drugs that target particular types of organism, to treat
specific infections and diseases. This will require understand-
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ing of the essential diﬀerences between the same target from
diﬀerent organisms. For enzyme targets, it will be important
to understand the diﬀerences in catalysis and mechanism.
Understanding and analysis of diﬀerences in activity and
specificity should assist in structure-based design of more
specific antimicrobials, targeting specific enzymes. The
origins of such diﬀerences are generally not obvious from
structural data alone: for example, diﬀerences in (e.g. carbape-
nemase) activity between various Class A beta-lactamases
cannot be discerned from their structures.9 However, mole-
cular simulations can identify diﬀerences, eﬀectively acting as
a ‘computational assay’ of biological activity,10 and – crucially
– analyze the physical origins of these diﬀerences at the mole-
cular level. For example, simulations of reactions with com-
bined quantum mechanics/molecular mechanics (QM/MM)
methods,11 distinguish Class A beta-lactamases that can
eﬃciently breakdown carabapenem antibiotics from enzymes
that cannot.12 Modelling of reactions in enzymes with QM/MM
methods can identify mechanisms13 and provide atomically
detailed knowledge about the key interactions of the substrate
(s), reaction intermediate(s) and transition state(s). It can
further identify specific role(s) of active site amino acids in cat-
alysis14 and conformational changes that the enzyme under-
goes in a catalytic cycle.15 Alongside explaining diﬀerences in
catalytic eﬃciency between enzymes, this detailed knowledge
potentially provides new perspectives for the structure- and
mechanism-based design of enzyme inhibitors.
Here, we present an extensive QM/MM simulation study of
the reaction free energy profile of two homologous enzymes of
a recognized target for antibiotic drug design, the type II de-
hydroquinase enzyme (DHQ2). The approach used, providing
detailed understanding of catalytic and mechanistic diﬀer-
ences, could be used generally for designing specific inhibitors
against enzymes present in certain pathogenic bacteria vs.
non-pathogenic ones, as well as aiding in the rationalization of
experimentally observed diﬀerences in inhibitor eﬃcacy
among homologous enzymes. In particular, the present study
compares the DHQ2 from Mycobacterium tuberculosis
(MtDHQ2) with that from Helicobacter pylori (HpDHQ2). We
identify, from QM/MM simulations, the key factors that
explain the 50-fold catalytic eﬃciency diﬀerence between the
two homologous enzymes.
DHQ2 (3-dehydroquinate dehydratase, EC 4.2.1.10) is the
third enzyme of the shikimic acid pathway through which ery-
throse-4-phosphate and phosphoenol pyruvate are converted
into chorismic acid. The latter is the precursor of important
aromatic metabolites such as the aromatic amino acids, folate
cofactors, ubiquinone and vitamins E and K.16 DHQ2, which is
encoded by the aroD/aroQ gene and does not have any counter-
part in human cells, is an essential enzyme for Mycobacterium
tuberculosis, which causes tuberculosis, as well as for
Helicobacter pylori, which is a major cause of gastric and duo-
denal ulcers and has been classified as a class I carcino-
gen.17,18 The enzyme is also present in the non-pathogenic
bacterium Streptomyces coelicolor,19 as well as the fungi
Aspergillus nidulans,20 and Neurospora crassa.21 DHQ2 is a
dodecamer (tetramer of trimers), with a trimer as the
minimum catalytic unit.22 It catalyzes the reversible dehydra-
tion of 3-dehydroquinic acid (1) to form 3-dehydroshikimic
acid (3) (Scheme 1). The enzymatic mechanism consists of an
overall anti elimination of water involving the loss of the more
acidic pro-S hydrogen from C2 in 1 via the enolate intermedi-
ate 2.23–25 Three residues have been identified by chemical
modification and site-directed mutagenesis studies as being
essential for enzyme activity. Two of them are located in a flex-
ible loop (henceforth the substrate-covering loop) that forms a
lid that closes the active site for catalysis: an arginine26 (Arg19/
Arg17 in MtDHQ2 and HpDHQ2, respectively; this order will
Scheme 1 Mechanism of the reaction catalyzed by the MtDHQ2 and HpDHQ2 enzymes. For HpDHQ2 (path a, magenta arrows) the generation of
the catalytic tyrosinate during the ﬁrst step involves a water molecule (W2, magenta) whereas for MtDHQ2 (path b, blue arrows) Tyr24 is suﬃciently
close to Asp88’ to for a direct deprotonation.
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be used throughout) and a tyrosine27 (Tyr24/Tyr22).28 The
third residue is an aspartate (Asp88′/Asp89′) from the neigh-
boring enzyme subunit (residues from this subunit will be
marked with an accent mark).25 The resolution of several
crystal structures of DHQ2 in complex with the product and
some reversible competitive inhibitors, in combination with
diverse biochemical and computational studies allows a
detailed description of the active site and provides a good
overall knowledge of the enzymatic mechanism. The substrate
is anchored to the active site by several hydrogen bonding
interactions through the carboxylate group and the hydroxyl
groups (Fig. 1B and C). Specifically, the carboxylate group,
which is key for recognition, establishes four strong hydrogen
bonding interactions involving the main chain amide NH
groups of Leu102/Ile103 and Ser103/Thr104, the side chain
hydroxyl group of Ser103/Thr104, and the side chain amide of
the conserved Asn75/Asn76.28 The latter also forms a second
hydrogen bond between its carbonyl group and the
C1 hydroxyl group, thereby positioning the hydroxyl group to
accept a proton from the conserved His101/His102. The main
hydrogen bonding interactions of the secondary hydroxyl
groups are with His81/His82 and Arg112/Arg113 (C5 hydroxyl
group), and Asp88′/Asp89′ (C4 hydroxyl group). In addition,
the C3 carbonyl group is anchored to the active site through a
structural water molecule (henceforth W1) that also hydrogen
bonds with residues Pro11/Pro9, Asn12/Asn10 and Gly78/
Ala79. Previous computational studies involving QM/MM
Steered Molecular Dynamics (SMD) simulations of the reaction
showed that the reaction is initiated by the essential aspartate
(Asp88′/Asp89′).25 This residue acts as the general base to
deprotonate the essential tyrosine to the catalytic tyrosinate
form, which triggers the enzyme-catalyzed chemical reaction.
For the HpDHQ2 enzyme, the deprotonation occurs with the
assistance of a water molecule (henceforth W2), while for
MtDHQ2, the tyrosine is directly deprotonated by the aspartate
residue. The latter is supported by results from solvent isotope
eﬀects and proton inventory studies.25 The necessary reduction
in pKa of Tyr24/Tyr22 has been proposed to be achieved by the
proximity of two conserved arginine residues, Arg108/Arg109
and Arg112/Arg113 and a cation–π interaction with the essential
Arg19/Arg17.29 MD simulation studies revealed that the latter
residues are also responsible for the release of the product from
the active site.25 Importantly, the essential arginine controls the
correct conformation of the tyrosinate for the removal of the
Fig. 1 (A) Amino acid sequence alignments for the M. tuberculosis, H. pylori, S. coelicolor, and A. nidulans DHQ2 enzymes. Protein sequences were
aligned using the CLUSTAL Omega multiple sequence alignment (http://www.ebi.ac.uk/Tools/msa/clustalo/, accessed July 1, 2017). Conserved and
essential residues are highlighted in blue and red, respectively. The substrate-covering loop and the residues involved in the recognition of C1, C4
and C5 positions of the natural substrate and the W1 pocket are shaded with a yellow box. (B, C) Detailed views of the active site residues in
Michaelis complex models for MtDHQ2 (B) and HpDHQ2 (C). Relevant residues are shown and labeled. Catalytic residues are indicated with green
carbons, substrate with yellow carbons. Hydrogen bonding interactions are indicated as red dashed lines.
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pro-S hydrogen from C2 in 1. The final step is the acid-catalyzed
elimination of the C1 hydroxyl group that is mediated by the
conserved histidine His101/His102 acting as a proton donor.
The previously reported computational studies on the mecha-
nism of DHQ2 either included a small model of the active site
(lacking the essential arginine or a detailed description of how
the catalytic tyrosinate is generated)24 or used limited
sampling of conformations on the reaction pathway using QM/
MM SMD25 studies. However, the over 50-fold catalytic
eﬃciency diﬀerence between the M. tuberculosis (kcat/Km = 22 ×
104 s−1 M−1)30 and H. pylori (kcat/Km = 0.4 × 10
4 s−1 M−1)30
enzymes could not be explained; the active site of the DHQ2
enzymes is highly conserved (Fig. 1A).
Here, we present an extensive semiempirical QM/MM
Umbrella Sampling simulation study, with corrections up to
the correlated ab initio (MP2) level, to explore the reaction free
energy profile of these two homologous enzymes. Detailed
analysis of the key rate-determining step, which involves the
formation of the enolate intermediate 2, allowed us to identify
relevant diﬀerences in this step that explain the experimentally
observed diﬀerence in catalytic eﬃciency of the two studied
enzymes, MtDHQ2 and HpDHQ2. The results shown here give
a detailed picture of the mechanism and identify relevant
interactions that could be used for future inhibitor design.
Results and discussion
QM/MM (SCC-DFTB/ﬀ03) umbrella sampling simulations were
performed for the two DHQ2 enzymes, MtDHQ2 and HpDHQ2,
and for the three reaction steps: (a) generation of the catalytic
tyrosinate, (b) formation of the enolate intermediate 2, and (c)
enolate dehydration (Scheme 1). In general, the resulting free
energy profiles at this level of theory indicate that the three-
step mechanism is feasible, with an overall energy barrier of
15.4 and 16.0 kcal mol−1 for MtDHQ2 and HpDHQ2, respect-
ively. The free energy profiles at the SCC-DFTB/ﬀ03 level
suggest that the enolate dehydration (3rd step) is the rate-deter-
mining step (Fig. S1†), whereas experimental isotope eﬀects
indicate that this is due to the formation of the enolate inter-
mediate 2 (2nd step).23 Small model calculations indicated that
this discrepancy is likely due to inaccuracies of SCC-DFTB for
the reaction (and activation) energy of the 2nd step, i.e. due to
inaccurate proton aﬃnities. Our results show that SCC-DFTB
underestimates the stability of the enolate intermediate 2 with
respect to the substrate (with tyrosinate) by between 6–8 kcal
mol−1, when compared with more accurate methods such as
MP2 and B3LYP (Fig. S2†). Thus, corrections at the MP2/6-
31+G(d,p) level to the energy profile for the 2nd step, give free
energy profiles for the three step mechanism with overall bar-
riers of 14.0 and 17.0 kcal mol−1 for MtDHQ2 and HpDHQ2,
respectively (Fig. 2). These energy values correlate reasonably
well with values derived from the experimentally determined
apparent catalytic rates (using the Arrhenius equation with a
unity pre-factor): 16.5 and 17.4 kcal mol−1 for MtDHQ2 and
HpDHQ2, respectively. Notably, the 2nd step is now rate-deter-
mining for both enzymes, in agreement with the experimental
data. A more detailed description of the corrections carried
out, as well as the main diﬀerences between the two enzymes
along the reaction path identified in the herein reported QM/
MM (SCC-DFTB/ﬀ03) umbrella sampling simulations is pro-
vided below.
1st step: Generation of the catalytic tyrosinate
Reaction barriers of 6.8 and 8.8 kcal mol−1 for MtDHQ2 and
HpDHQ2, respectively, were found for this step (Fig. 2). The
∼2 kcal mol−1 diﬀerence between the enzymes can be
explained by the distinct nature of the process (Fig. 3). While
for MtDHQ2 the essential Tyr24 is deprotonated directly by the
essential Asp88′, for HpDHQ2, the process is mediated by a
water molecule (W2), which is located between Tyr22 and
Asp89′. W2 is observed in diverse crystal structures of binary
HpDHQ2/inhibitor complexes such as PDB 4B6R (Fig. 4).31 It
seems that W2 supplements the inability of the essential Tyr22
to be located close enough to the catalytic Asp89′ for direct
proton transfer. This is mainly due to the salt bridge present
during the whole reaction between Asp18 and Arg20, both
located in the substrate-covering loop, which controls and
limits active site flexibility. This strong interaction, which is
not present in MtDHQ2 (Fig. 1A, Glu20 and Ala22 are present
in equivalent positions), has been proposed to control and
reduce the plasticity of this loop (Fig. S2†).31 In addition, the
presence of Glu20 in the loop of MtDHQ2, replacing the
shorter Asp18 in HpDHQ2, favours the interaction between
Glu20 and the neutral Asp88′. In fact, we observed that after
performing the Umbrella Sampling simulation for the 2nd step
(forming the substrate 1), this interaction leads to a large dis-
tance between Tyr24 and the neutral Asp88′ (average distance
of 5.1 Å between the Tyr24 hydroxyl O and the Asp88′ car-
boxylic acid H). To avoid this issue, we introduced an
Fig. 2 Free energy proﬁles obtained using Umbrella Sampling simu-
lations at the SCC-DFTB/ﬀ03 level for the whole reaction in both DHQ2
enzymes [MtDHQ2 (blue), HpDHQ2 (magenta)]. For the 2nd step, free
energies were corrected using single point MP2/6-31+G(d,p) calcu-
lations. For the 1st step in HpDHQ2 and the 3rd step in both enzymes,
minimum free energy paths extracted from 2D free energy surfaces are
shown.
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additional reaction coordinate (and performed QM/MM
umbrella sampling along this coordinate) to reduce the dis-
tance between Tyr24 and Asp88′ and to break the interaction
between Glu20 and neutral Asp88′.
Significant diﬀerences in the behaviour of the structural
water molecule W1 for both enzymes were identified. While
for the MtDHQ2 enzyme, the four hydrogen bonding interactions
that anchor W1 to the active site (also observed in the Michaelis
complex and involving residues Pro11, Gly78 and Asn12 and the
C3 ketone in 1) remained unchanged during the whole mecha-
nism, this is not the case for HpDHQ2 (Fig. 3B vs. C). For
HpDHQ2, only the interactions involving residues Pro9 and Ala79
remained present during the whole mechanism since Asn10
forms a hydrogen bond with Asp89′ (Fig. 3C). As a consequence,
W1 rotates during the 2nd step to form a hydrogen bond with the
O3 atom of the forming enolate, an equivalent interaction as
observed for theMtDHQ2 enzyme.
Overall, the reaction energy for the 1st step is almost identi-
cal (0.7 kcal mol−1 diﬀerence, Fig. 2). The capability of both
enzymes for stabilization of the catalytic tyrosinate is therefore
similar. For both enzymes, the formation of the catalytic tyrosi-
nate occurs with a parallel arrangement between the phenol
group of the essential tyrosine and the guanidinium group of
the essential arginine Arg19/Arg17 (Fig. 3A and D). This
arrangement helps to maximize the cation–π interaction
between both residues, which has been proposed to (a) control
the appropriate position of the tyrosinate for abstraction of the
pro-S hydrogen atom from C2 in 1; and (b) to reduce the pKa of
the tyrosine, along with the conserved Arg108/Arg109 residue.29
The latter residue is likely to set up the catalytic tyrosine or W2
(in MtDHQ2 and HpDHQ2, respectively), for deprotonation.
Once the tyrosinate was formed, this parallel arrangement
between Tyr24/Tyr22 and Arg19/Arg17 was partially lost,
although both residues remain close (Fig. 3A and D).
2nd step: Enolate formation
As aforementioned, simulations of the full reaction with
SCC-DFTB fail to predict the 2nd step as the partial rate deter-
mining step of the reaction path, due to the overestimation of
the energy for hydrogen abstraction, as well as the underesti-
mation of the reaction barrier by SCC-DFTB (Fig. S3†); such
limitations are typical of this eﬃcient but approximate
density-functional theory method (with the recent third-order
parametrization showing promising improvement).32 To over-
come this issue, several high-level QM methods (ab initio MP2,
and DFT: B3LYP and MPW1K) were employed to correct the
free energy profile of this 2nd step, using energy calculations
on SCC-DFTB/MM potential energy profiles. All showed the
Fig. 3 (A) & (D) Comparison of the position of Tyr24/Tyr22 and Arg19/Arg17 residues in the reactants (green), transition state (gray) and products
(orange) of the 1st step of the reaction in MtDHQ2 (A) and HpDHQ2 (D). (B) & (C) Representative geometries of the transition state for the formation
of the catalytic tyrosinate (1st step) in QM/MM umbrella sampling simulations for MtDHQ2 (B) and HpDHQ2 (C). Relevant residues are shown and
labeled. Key hydrogen bonding interactions and bonds broken/formed are indicated as dashed lines.
Fig. 4 Unbiased electron density for (2S)-2-perﬂuorobenzyl-3-dehy-
droquinic acid (yellow, inhibitor), W1, W2 and Asp89’ in the binary
HpDHQ2/inhibitor complex (chains A and C, PDB code 4B6R,31 1.9 Å). A
maximum-likelihood weighted 2Fo − Fc map contoured at 1σ is shown
up to 1.6 Å around the inhibitor molecule (blue), W1 and W2 (red) and
Asp89’ (green).
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same trends, so only the ab initio MP2 results are discussed
here (Fig. S4†). Moreover, these QM methods also provide an
energy profile for this step with the typical proton-transfer
curve, which was not observed using SCC-DFTB. These correc-
tions not only allow the correct identification of the partially
rate-determining 2nd step, but also serve to assess the nature
of the process and the diﬀerence between the two homologous
enzymes. Once corrected, the formation of 2 is thermo-
dynamically favorable for both enzymes, by −3.8 and −0.6
kcal mol−1 (for MtDHQ2 and HpDHQ2, respectively). As a
result, MtDHQ2 stabilizes the enolate intermediate 2 more
eﬀectively than HpDHQ2, with a relative diﬀerence compared
to the Michaelis complex of 3.9 kcal mol−1. Further, the energy
barrier for the transition state (henceforth TS1) in MtDHQ2 is
lower than for HpDHQ2 (11.7 vs. 14.0 kcal mol−1).
We evaluate the electrostatic contributions to stabilisation
of enolate intermediate 2 and TS1 of key residues (Arg19/Arg17
and Asp88′/Asp89′) and the structural and catalytic water mole-
cules W1 and W2 (Tables 1, S1 and S3†). Significant diﬀer-
ences between the two enzymes are identified for each (Fig. 5).
Arg19/Arg17. For both enzymes this is the main residue
stabilizing the enolate intermediate 2. Blomberg et al. did not
include the equivalent Arg23 in their calculations of DHQ2
from S. coelicolor,24 thus predicting an endoergic process for
enolate formation (with energy values ranging between
11.3–14.5 kcal mol−1). This confirms the important role of this
essential Arg in the stabilization of 2 in DHQ2 enzymes.
Table 1 Contributions of Arg19/Arg17 and Asp88’/Arg89’ and water
molecules W1 and W2 to the stabilization of TS1 and the enolate inter-
mediate 2 relative to substrate and tyrosinate state (kcal mol−1)a
Residue/water molecule
TS1
Enolate
intermediate 2
MtDHQ2 HpDHQ2 MtDHQ2 HpDHQ2
Arg19/Arg17 −2.74 4.30 6.20 15.21
Asp88′/Asp89′ 1.51 −2.07 1.67 −4.56
W1 1.13 0.89 4.03 2.89
W2 n/a −8.60 n/a −16.89
a Energy values were obtained from single point MP2/6-31+G(d,p) cal-
culations and as a diﬀerence of the relative energy (with respect to the
reactants) of the QM region without the residue minus the energy of
the full QM region. Positive values indicate stabilization with respect
to the reactants (substrate and tyrosinate state).
Fig. 5 Representative geometries of the catalytic tyrosinate (A & D), TS1 (B & E) and enolate intermediate 2 (C & F) for the 2nd step of the MtDHQ2
(A–C) and HpDHQ2 (D–F) mechanism. Geometries were taken from the potential energy surface. Relevant residues and water molecules are shown
and labeled. Key hydrogen bonding interactions and bonds broken/formed are indicated as red dashed lines.
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However, the contribution of this residue to stabilization of
TS1 was found to be diﬀerent for MtDHQ2 and HpDHQ2. In
HpDHQ2, this residue strongly stabilizes TS1, whereas this is
not the case in MtDHQ2. A key structural diﬀerence is that in
HpDHQ2, Arg17 is in close (hydrogen bonding) contact with
the ketone group of the substrate (during formation of TS1),
whereas in MtDHQ2 interaction of the guanidinium group of
Arg19 with the substrate is rather distant in TS1 (Fig. 6). Thus,
for HpDHQ2, the essential arginine is mainly interacting with
the ketone group, whereas in MtDHQ2 it is mostly with the
essential tyrosine. Average distances between the NH1, NH2
and CZ atoms in Arg19/Arg17 and the O3 atom in TS1 in the
umbrella sampling window for TS1 revealed similar values for
both enzymes (3.3, 2.9 and 3.5 Å for HpDHQ2 and 2.9, 3.2 and
3.5 Å for MtDHQ2). However, the average distance between the
centre of masses of the guanidinium group in Arg19/Arg17
and the phenol group in Tyr24/Try22 is somewhat diﬀerent
(3.5 Å for MtDHQ2 and 4.4 Å for HpDHQ2). Taken together,
this shows that (a) the cation–π interaction between Arg19 and
Tyr24 appears stronger for MtDHQ2 than for HpDHQ2, (b) in
MtDHQ2, Arg19 is exclusively involved in the stabilization of
the enolate intermediate 2 and positioning of the catalytic tyro-
sine for triggering the reaction, and (c) in HpDHQ2, Arg17 has
the additional role of activating/positioning the substrate for
enolate formation. The distinct role and arrangement of the
essential tyrosine for catalysis as well as the enolate stabiliz-
ation in both enzymes can explain the marked inhibitory
potency diﬀerences of previously reported reversible competi-
tive inhibitors based on the natural substrate and the enolate
intermediate. For HpDHQ2, compounds in which the pro-S
hydrogen of C2 in 1 was replaced by diverse benzyl groups,
compounds 4, have Ki values from 1.4 to 0.9 µM, whereas their
inhibitory potency against MtDHQ2 increases up to 25-fold
(56 to 100 nM) (Table 2).33 These inhibitors, which reduce the
plasticity of the substrate-covering loop avoiding the cation–π
interaction between Tyr24/Tyr22 and Arg19/Arg17 required for
catalysis, are more potent against MtDHQ2 because the flexi-
bility of its loop needs to be suﬃciently large to locate Tyr24
close enough to Asp89′ for deprotonation. Further, 3-O-alkyl-
aryl mimics of the enolate intermediate 2, compounds 5, are
more potent against MtDHQ2 than against HpDHQ2, which is
related to the more eﬀective stabilization of 2 in MtDHQ2
shown here.34,35
Asp88′/Asp89′. While for MtDHQ2, Asp88′ contributes favor-
ably to the stabilization of both the enolate intermediate 2 and
TS1, the opposite eﬀect is observed for Asp89′ in HpDHQ2.
This can be explained from the distinct orientation adopted by
the neutral Asp88′/Asp89′ side chain and the eﬀects that this
arrangement causes in the nearby residues. In MtDHQ2, the
proton of the neutral Asp88′ hydrogen bonds to the side chain
of Glu20 (thus keeping Asp88′ away from where the enolization
reaction takes place). In contrast, Asp89′ hydrogen bonds to
the catalytic water moleculeW2 in HpDHQ2, placing the carbo-
nyl oxygen atom of Asp89′ close to the developing negative
charge of enolate 2 O3 (Fig. S5†).
Structural water molecule W1. W1 has a favorable contri-
bution to stabilization of both TS1 and the enolate 2 in both
enzymes (Table 1). This eﬀect can be explained by the hydro-
gen bond between W1 and the O3 oxygen atom of the forming
enolate found in both cases, which helps to stabilize the devel-
oping negative charge on this atom. The importance of this
water molecule for inhibitor binding to DHQ2 has been pre-
viously demonstrated: replacing the oxygen atom in the side
chain of 3-O-alkylaryl mimics of the enolate intermediate 2,
compounds 5, by a carbon atom (3-alkylaryl derivatives, com-
pounds 6) leads to a decrease in the inhibitory potency up to
20-fold (Table 2).34–36 MD simulations of both enzyme/inhibi-
tor complexes showed that this substitution causes an increase
in the distance between the oxygen atom of the side chain
inhibitors and W1 of about 1 Å, resulting in the loss of a favor-
able polar interaction.37 In addition, a Comparative Binding
Fig. 6 Comparison of TS1 in the MtDHQ2 (colored as wheat) and
HpDHQ2 (green) mechanism. Note that while the arrangement and
position of Tyr24/Try22 is quite similar for both enzymes, this is no
longer the case for Arg19/Arg17. For HpDHQ2, the essential Arg17 is dis-
placed by about 1.9 Å.
Table 2 Ki (nM) of selected examples of reversible competitive inhibi-
tors of MtDHQ2 and HpDHQ2 enzymes
Compd Ar MtDHQ2 HpDHQ2 Ref.
4a (4-OMe)C6H4 100 1420 33
4b Benzo[b]thiophen-5-yl 56 900 33
4c C6F5 74 970 33
5a Benzo[b]thiophen-5-yl 28 132 34 and 35
5b Naphth-2-yl 35 310 34 and 35
6a Benzo[b]thiophen-5-yl 254 2460 36
6b Naphth-2-yl 436 790 36
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Energy (COMBINE) analysis carried out with more than 50
competitive reversible inhibitors of both DHQ2 enzymes
revealed that the interaction of the inhibitors with W1 is the
most significant contribution to the inhibitory potency.37
Catalytic water molecule W2. The significant destabilization
of both TS1 and the enolate intermediate 2 by W2 (only
present in HpDHQ2) is surprising (Table 1). To ascertain if this
result could be due to a strained arrangement of W2 in the
potential energy surface conformations, the electrostatic inter-
actions of W2 were also calculated for 50 snapshots from the
umbrella sampling windows of the reactant, transition state
and product of the 2nd step. No minimization was performed
on any of these complexes. Average values of −8.6 ± 0.5 and
−16.9 ± 0.3 kcal mol−1 (at the SCC-DFTB level of theory) were
obtained for TS1 and 2, respectively (relative to the reactant
state), revealing no significant diﬀerence to those obtained
from the potential energy surface (−8.0 and −14.6 kcal mol−1;
Table S1†). Even if only the tyrosinate anion and the substrate
were included in the energy calculation (either in presence or
absence of W2) significantly negative values for TS1 and 2
(−5.9 and −11.6 kcal mol−1, respectively) were obtained. Single
point calculations of the strength of hydrogen bonds between
W2 and the catalytic tyrosinate and the enolate 2 using the
geometries from the potential energy surface, show that the
hydrogen bond with the catalytic tyrosinate is much stronger
than that with the enolate 2 (Table S3†). This is in line with
the hydrogen bond distances (distance between the W2 hydro-
gen and the O3 oxygen atom in 2 is 2.7 Å in the potential
energy surface structure and 2.2 Å (average value) in the
ensemble of the QM/MM simulation for the products, whereas
the W2 hydrogen to tyrosinate oxygen distances are 1.66 Å and
1.81 Å, respectively). The position of W2 is not aﬀected signifi-
cantly by the restraints used to prevent W2 exchange with a
water molecule from the MM region: a 50 ps QM/MM MD
simulation of the product state without the relevant restraints,
showed that after 26–27 ps, W2 leaves its position and was
almost immediately replaced by another water molecule; in
other words, the simulations show this position to be almost
always occupied by a water molecule, but some exchange of
the water molecule at this site occurs on the MD timescale.
Before and after the exchange, strong hydrogen bonding inter-
actions with Arg109 are present, but not with enolate 2
(Fig. S6†). Taken together, the results of these studies indicate
that the water molecule W2 is mainly responsible of the lower
catalytic eﬃciency of the H. pylori enzyme: the use of a water
molecule for the generation of the catalytic tyrosinate, necess-
ary due to the reduced flexibility of its substrate-covering loop,
causes less favorable interactions at the rate-determining step
of the enzymatic conversion, resulting in a lower catalytic rate.
3rd step: Enolate dehydration
No significant diﬀerences between the two enzymes were
identified for this step either in energy or geometry (Fig. 7).
Similar free energy barriers (8.4 and 7.9 kcal mol−1) and reac-
tion energies (−7.8 and −6.7 kcal mol−1) were obtained for
MtDHQ2 and HpDHQ2, respectively. In contrast, Blomberg
et al.24 reported a great variability for the energies barriers cal-
culated for this step and for the energy of the whole process
for the Streptomyces coelicolor enzyme. In particular, the energy
barrier for the two step mechanism (enolate formation and
enolate dehydration) found previously with DFT ranged
between 14.4 and 22.5 kcal mol−1 and showing a maximum
energy for the transition state of the enolate dehydration (TS2),
and the energy of the transformation ranged between −8.2 to
9.2 kcal mol−1. Our model is more consistent with the experi-
mental data, with a barrier located in the TS1 for the for-
mation of the enolate 2, and an overall energy of −9.3 and
−4.3 kcal mol−1 (for MtDHQ2 and HpDQH2, respectively) for
the three step mechanism.
Taken together, the calculations reported herein allow the
quantification of small diﬀerences in the energy barriers of
catalytic processes carried by homologous enzymes, which is
mainly related to kcat. The diﬀerences in recognition (Km)
between both enzymes, which in this case are also experi-
mentally significant and have an important impact on the
overall process catalyzed by the enzyme (kcat/Km), cannot be
quantified by this type of computational study. However, the
knowledge in atomic detail of the geometry of the Michaelis
complex, transition states and intermediates of the catalytic
process in both enzymes and more importantly, the relevant
diﬀerences found between the mechanisms of both enzymes
in terms of interactions between the enzyme and reacting
species provides a good understanding of the experimentally
observed diﬀerences in eﬃciency [M. tuberculosis (fast)
vs. H. pylori (slow)].
Fig. 7 Representative geometries of TS2 (A & C) and products (B & D)
for the 3rd step of the MtDHQ2 (A–B) and HpDHQ2 (C–D) mechanism.
Geometries taken from the potential energy surface. Relevant residues
and water molecules are shown and labeled. Key hydrogen bonding
interactions and bonds broken/formed are indicated as red dashed lines.
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Conclusions
In the present study we have shown that a combined approach
using QM/MM umbrella sampling simulations at the
SCC-DFTB/ﬀ03 level of theory with MP2/6-31+G(d,p) correc-
tions on the key reaction step of the reaction catalyzed by the
DHQ2 enzyme provides free energy profiles in agreement with
experimental data. No significant energetic diﬀerences were
found for the generation of the catalytic tyrosinate and the
enolate dehydration steps in the MtDHQ2 and
HpDHQ2 homologues. The 2nd step is rate-determining, in
line with experiment (and in contrast with previously reported
computational studies), and it is this step which gives rise to
observed diﬀerences in activity between the two enzymes.
Quantification of the contribution of relevant residues in the
rate-determining step allowed the identification of the key
factors responsible for the 50-fold catalytic eﬃciency diﬀer-
ence between two homologous enzymes, MtDHQ2 and
HpDHQ2. The more eﬃcient stabilization of the enolate inter-
mediate by the M. tuberculosis enzyme results in a thermo-
dynamically more favorable 2nd step (ΔG −3.8 kcal mol−1) than
for its H. pylori homologue (−0.6 kcal mol−1). For HpDHQ2, a
conserved water molecule (W2) between the catalytic residues
Asp89′ and Tyr22 was found to destabilize both the transition
state (TS1) and the enolate product 2 of the 2nd step. The water
molecule W2 that is required for the 1st step in HpDHQ2
(probably to compensate for the inability to locate both resi-
dues close enough for the generation of the catalytic tyrosi-
nate) leads to a less optimal arrangement of the active site for
the subsequent steps of the enzymatic conversion. The pres-
ence of W2 (and the lack of the Asp–Glu interaction observed
in MtDHQ2) also contributes to the destabilising influence of
Asp89′ (compared to stabilization by Asp88′ in MtDHQ2). The
requirement for W2 in HpDHQ2 is probably determined by the
more limited flexibility of the substrate-covering loop in this
enzyme, due to the formation of an internal salt bridge
between two residues of this loop, Asp18 and Arg20.
Comparison of the amino acid sequence of the catalytic loop
in diverse DHQ2 homologous enzymes reveals that MtDHQ2 is
the only one with an apolar residue in one of the corres-
ponding positions (Ala22; Fig. 1A), which appears to be crucial
for its larger flexibility.31
Our quantification of the contributions of the key residues
in the rate-determining step of the mechanism provides a
better understanding of the higher inhibitory potencies of
known mechanism-based inhibitors, i.e. analogs of the natural
substrate and the enolate intermediate. Whereas the crystal
structures of the binary DHQ2/ligand complexes for both
enzymes show a highly similar binding mode (e.g. PDB codes
4B6O31 and 2Y7135 for MtDHQ2 and PDB codes 4B6R31 and
2WKS34 for HpDHQ2), the inhibitors present in these struc-
tures have significantly distinct inhibitory potencies. The
identified more eﬃcient stabilization of the enolate intermedi-
ate and TS1 by the M. tuberculosis enzyme explains the diﬀer-
ence in inhibition data and will be helpful for ongoing inhibi-
tor design. The computational studies presented here high-
light the potential of QM/MM simulations as a tool for under-
standing diﬀerences in catalytic eﬃciency between homolo-
gous enzymes.
Experimental
System preparation
Initial structures were prepared as in ref. 25. For MtDHQ2, the
coordinates from the crystal structure of the M. tuberculosis
enzyme in complex with the product, 3-dehydroshikimic acid
(3) (Protein Databank (PDB) code 3N59),38 were used. For
HpDHQ2, the crystal structure PDB 2XB9,29 which has the
inhibitor (2R)-2-(4-methoxybenzyl)-3-dehydroquinic acid in the
active site, was employed. For MtDHQ2, the reaction mecha-
nism was studied in the forward (formation of 3) and back-
ward direction (formation of 1). Because the latter provided
more reliable results with less motion of the key residues (in
line with eﬃcient reaction), both enzymatic conversions are
studied and compared in the direction of formation of 1 here.
The ligand present in the PDB 2XB9 structure was replaced by
the product, 3-dehydroshikimic acid (3). Except the structural
water molecule (W1), all crystallographic waters were removed.
The addition of missing hydrogen atoms and protonation
states of residues were assigned using the H++ web server at
pH 7.0 (http://biophysics.cs.vt.edu/H++),39 except for Asp88′/
Asp89′ that was treated as protonated due to mechanistic con-
siderations. The ﬀ0340 AMBER force field and GAFF41 were
used to assign bonded and non-bonded parameters to the
protein and both 3-dehydroquinic acid (1) and 3-dehydroshiki-
mic acid (3), respectively. Each complex was immersed in a
truncated octahedron of TIP3P42 water molecules and neutral-
ised with Na+ ions43 (∼20 000 water molecules and 15 Na+ ions
for the MtDHQ2 model and ∼30 000 water molecules and 16
Na+ ions for the HpDHQ2 model were added).
Molecular dynamics simulations
Simulations were performed using the sander and pmemd
modules of AMBER 12.44 Periodic boundary conditions were
applied and electrostatic interactions were treated using the
smooth PME (particle mesh Ewald) method45 with a grid
spacing of 1 Å. The cut-oﬀ distance for the nonbonded inter-
actions was 9 Å, the SHAKE46 algorithm was applied to all
bonds and an integration step of 2.0 fs was used throughout.
After an initial energy minimization of the water molecules
and counter ions, both systems were heated to 300 K in 25 ps
using positional restraints of 50.0 kcal mol−1 Å−2 for the
protein Cα atoms. The HpDHQ2 model was then equilibrated
over 200 ps with the positional restraints, which were sub-
sequently reduced by 5.0 kcal mol−1 Å−2 every 20 ps, followed
by 20 ps without restraints. The MtDHQ2 model (with coordi-
nates from 3 already present in the crystal structure) was equi-
librated for 100 ps using restraints of 5.0 kcal mol−1 Å−2 for
the protein Cα atoms (except for amino acids Asp89′, Arg19
and Glu20). Subsequently, restraints were reduced by 1.0 kcal
mol−1 Å−2 every 20 ps, and another 20 ps without restraints. To
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maintain a catalytically relevant conformation, a restraint of
100 kcal mol−1 Å−2 was used to keep the dihedrals CB, CG,
OD2, HD2 of Asp88′ at 180° and CA, CB, CG, OD2 of Asp89′
between 120° and −60°. Two further one-sided distance
restraints of 15 kcal mol−1 Å−2 were used: one to keep the
CGAsp89′–CDGlu20 distance to within 4 Å and another to keep
the CDGlu20–CZArg108 distance to at least 6.5 Å, in order to
avoid distortion of the active site. For both models, the final
equilibration snapshot was used for mechanistic studies with
QM/MM MD.
QM/MM MD simulations
For both enzymes, the QM region included the equivalent
atoms of the product, 3-dehydroshikimic acid (3), the side
chains of residues Arg19/Arg17, Tyr24/Tyr22, His101/His102
and Asp88′/Asp89′, and the product and structural (W1) and
product (henceforth W3) water molecules. For the
HpDHQ2 model, a second water molecule, W2, that was
observed located between Tyr22 and Asp89′ was also included.
Hydrogen ‘link atoms’47,48 were used to model bonds across
the QM/MM boundary, specifically between Cγ and Cδ of
Arg19/Arg17, Cα and Cβ of Tyr24/Tyr22, His101/His102 and
Asp88′/Asp89′. W3 was manually docked in the carboxylate
recognition pocket, establishing one hydrogen bond with the
Oδ1 oxygen atom of Asn75/Asn76 and another one with the
Nδ1 nitrogen atom of His101/His102. QM/MM calculations
were performed using sander from AMBER 12 (version 12.19).
SCC-DFTB49 was used for the QM region.
QM/MM umbrella sampling MD simulations were run for
each reaction step, harmonically restraining the reaction coor-
dinate with a force constant of 100 kcal mol−1 Å−2. Each simu-
lation (window) consisted of 5 ps (10 000 steps with an inte-
gration step of 0.5 fs) of sampling and the reaction coordinate
was increased (or decreased) by 0.1 Å between neighboring
windows, using the last geometry of the previous window as
starting point. Values of the reaction coordinate were collected
for all simulation steps. The free-energy profiles for each step
were obtained by combining the statistics from all simulations
for that reaction using the weighted histogram analysis
method (WHAM).50–52 The following reaction coordinates were
used: (i) third step – for both enzymes, a 2D umbrella sampling
simulation involving the formation of the C1–oxygen bond
in 1, and the proton transfer from W3 to His101/His102 was
used: r1a = d(C1–OW3) and r1b = d(ND1His–H1W3) − d(H1W3–
OW3). (ii) second step – for both enzymes, a single reaction coor-
dinate for the hydrogen addition to C2 in 1 by Tyr24/Tyr22 was
used: r2 = d(HHTyr–C2) − d(HHTyr–HOTyr). Moreover, several
additional restraints were employed to avoid sampling
rearrangements not related to the chemical steps of interest
(e.g. ligand unbinding, see ESI† for details). (iii) first step – For
the MtDHQ2 model, a single reaction coordinate for protona-
tion of the catalytic tyrosinate Tyr24 was employed: r3a =
d(OHTyr22–HD2Asp89′) − d(HD2Asp89′–OD2Asp89′), and an
additional reaction coordinate was needed for the approach of
the neutral Asp89′ to the tyrosinate anion (see ESI† for details).
For the HpDHQ2 model, 2D umbrella sampling with two reac-
tion coordinates was required: (1) deprotonation of W2 by tyro-
sinate Tyr22, and (2) protonation of W2 by neutral Asp88′, r3a =
d(OHTyr22–H1W2) − d(H1W2–OW2) and r3a = d(HD2Asp88′–OW2)
− d(HD2Asp88′–OD2Asp88′).
High level QM corrections and residue contributions for the
2nd step
For both enzymes, snapshots of the 0.0 Å window in the 2nd
step were minimized in a three step procedure: (1) 500 steps
(20 steepest descent followed by 480 conjugate gradient) with
the same restraints used in umbrella sampling but with a force
constant of 2500 kcal mol−1 Å−2; (2) minimization using the
LBFGS method (ntmin = 3) and a convergence criterion of
0.002 kcal mol−1 (drms = 0.002) keeping only restraints to the
reaction coordinate; (3) minimization with positional
restraints of 50 kcal mol−1 Å−2 to any residue, water molecule
or ion that was more than 5.0 Å away from the QM region and
the restraint of the reaction coordinate. The reaction coordi-
nate (between −1.1 to 1.0 Å for MtDHQ2 and −1.2 to 1.5 Å for
HpDHQ2) was explored forwards and backwards until a con-
verged and smooth (adiabatic) potential energy profile along
the reaction pathway was obtained. Coordinates for the QM
region (with H link atoms) along the reaction pathway were
then extracted and single point energy calculations in vacuum
with Gaussian0953 with SCC-DFTB and MP2 (with the 6-31+G
(d,p) basis set) were performed. SCS-MP2,54 B3LYP55,56 and
MPW1K57 single point energy calculations were also per-
formed. Corrections to the potential and free energy surfaces
(PES and FES) were applied by subtracting the energy calcu-
lated for the QM region using SCC-DFTB and adding the
energy from the MP2 (or other) calculations. Similar
approaches have been applied successfully previously to other
enzyme-catalyzed reactions;58,59 it corrects for limitations of
the lower-level method e.g. in the calculation of proton
aﬃnities. Individual electrostatic contributions for residues
Asp88′/89′ and Arg19/Arg17 and water molecules W1 and W2
(only HpDHQ2) were then evaluated by calculating the diﬀer-
ence between the energy profile with or without the corres-
ponding residue present. These energies were calculated as
single points with the same methods as before.
Due to the more complicated reaction coordinate for the 3rd
step (involving carbon–oxygen bond breaking as well as a
proton transfer, which necessitates two-dimensional umbrella
sampling) as well as relevant solvent rearrangements, a similar
energy correction based on single-point energies from a poten-
tial energy profile is not reliable for this reaction step.
Nevertheless, we performed such a correction to give an
approximate indication of how the reaction is aﬀected by more
accurate QM treatment (Table S7†). The approximate correc-
tions would lead to free-energy barriers for step 3 (relative to
the reactant state) of ∼11.5 kcal mol−1 for MtDHQ2 and
∼16.1 kcal mol−1 for HpDHQ2. In cases such as this, simple
potential energy profiles of enzyme reactions suﬀer from
extreme variability due to conformation variability and sol-
vation changes and are not an eﬀective approach to modelling
the mechanism. Single structures do not represent the ensem-
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ble of structures, and structural changes involved in reaction.
Indeed, if this approach were applicable, we would have fol-
lowed such an approach, as we have done in some previous
work. It is not in this case, as we have established by test calcu-
lations. Instead, it is essential to sample conformational
changes and generate appropriate structural ensembles for the
reacting system through QM/MM molecular dynamics simu-
lations. This necessitates the use of a low-level QM/MM
method, in this case SCC-DFTB, with corrections where
necessary (see below). We have discussed these factors
(and approaches to modelling enzyme reactions in general) in
ref. 11 and 60–62 as well as in a large number of published
applications (ref. 12 and 63).
Specific errors for sampling can be obtained by repeating
the reaction simulations multiple times. Where we have
done this in the past using a similar approach (and known
enzyme–substrate complexes), we find standard deviations of
0.1–1 kcal mol−1.12
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